Business NewsPR NewsWire • Watson and Richter Announce Exclusive License Agreement for Esmya™

Watson and Richter Announce Exclusive License Agreement for Esmya™

Watson and Richter Announce Exclusive License Agreement for Esmya™

MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem,

View More : http://www.prnewswire.com/news-releases/watson-and-richter-announce-exclusive-license-agreement-for-esmya-111982809.html
Releted News by prnewswire
Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
Watson and Richter Announce Exclusive License Agreement for Esmya™
Solarfun Expands North American Presence, Supporting Commitment to Growing Market
UK High Street Gambling With Stock Shortages in Crucial Christmas Shopping Period
Autonomy Named to Bloomberg Businessweek Hot Tech 50 Ranking